Delays in approving genetically modified crops and foods in the European Union have led to a high profile trade conflict with the United States. This book analyses the EU-US conflict and uses it as a case study to explore the governance of new technologies.

The transatlantic conflict over GM crops and food has been widely attributed to regulatory differences that divide the EU and the US. Going beyond common stereotypes of these differences and their origins, this book analyses the conflict through contending coalitions of policy actors operating across the Atlantic. Governing the Transatlantic Conflict over Agricultural Biotechnology focuses on interactions between the EU and the US, rather than on EU-US comparisons. Drawing on original research and interviews with key policy actors, the book shows how EU-US efforts to harmonise regulations for agricultural biotechnology created the context in which activists could generate a backlash against the technology. In this new context regulations were shaped along different lines. Joseph Murphy and Les Levidow provide new insights by elaborating critical perspectives on global governance, issue-framing, standard-setting and regulatory science.

This accessible book will appeal to undergraduate and post-graduate students, academics and policy-makers working on a wide range of issues covered by political science, policy studies, international relations, economics, geography, business management, environmental and development studies, science and technology studies.

Delays in approving genetically modified crops and foods in the European Union have led to a high profile trade conflict with the United States. This book analyses the EU-US conflict and uses it as a case study to explore the governance of new technologies.

The transatlantic conflict over GM crops and food has been widely attributed to regulatory differences that divide the EU and the US. Going beyond common stereotypes of these differences and their origins, this book analyses the conflict through contending coalitions of policy actors operating across the Atlantic. Governing the Transatlantic Conflict over Agricultural Biotechnology focuses on interactions between the EU and the US, rather than on EU-US comparisons. Drawing on original research and interviews with key policy actors, the book shows how EU-US efforts to harmonise regulations for agricultural biotechnology created the context in which activists could generate a backlash against the technology. In this new context regulations were shaped along different lines. Joseph Murphy and Les Levidow provide new insights by elaborating critical perspectives on global governance, issue-framing, standard-setting and regulatory science.

This accessible book will appeal to undergraduate and post-graduate students, academics and policy-makers working on a wide range of issues covered by political science, policy studies, international relations, economics, geography, business management, environmental and development studies, science and technology studies.

Europe was told that it had no choice but to accept agbiotech, yet this imperative was turned into a test of democratic accountability for societal choices. Since the late 1990s, European public controversy has kept the agri-biotech industry and its promoters on the defensive. As some opponents and regulators alike have declared, ‘GM food/crops are on trial’. Suspicion of their guilt has been evoked by moral symbols, as disputes over whether genetically-modified products are modest benign improvements on traditional plant breeding, or dangerous Frankenfoods; and in disputes over whether they are global saviours, or control agents of multinational companies. This book examines European institutions being ‘put on trial’ for how their regulatory procedures evaluate and regulate GM products, in ways which opened up alternative futures. Levidow and Carr highlight how public controversy created a legitimacy crisis, leading to national policy changes and demands, in turn stimulating changes in EU agbiotech regulations as a strategy to regain legitimacy.

Europe was told that it had no choice but to accept agbiotech, yet this imperative was turned into a test of democratic accountability for societal choices. Since the late 1990s, European public controversy has kept the agri-biotech industry and its promoters on the defensive. As some opponents and regulators alike have declared, ‘GM food/crops are on trial’. Suspicion of their guilt has been evoked by moral symbols, as disputes over whether genetically-modified products are modest benign improvements on traditional plant breeding, or dangerous Frankenfoods; and in disputes over whether they are global saviours, or control agents of multinational companies. This book examines European institutions being ‘put on trial’ for how their regulatory procedures evaluate and regulate GM products, in ways which opened up alternative futures. Levidow and Carr highlight how public controversy created a legitimacy crisis, leading to national policy changes and demands, in turn stimulating changes in EU agbiotech regulations as a strategy to regain legitimacy.

Delays in approving genetically modified crops and foods in the European Union have led to a high profile trade conflict with the United States. This book analyses the EU-US conflict and uses it as a case study to explore the governance of new technologies.

The transatlantic conflict over GM crops and food has been widely attributed to regulatory differences that divide the EU and the US. Going beyond common stereotypes of these differences and their origins, this book analyses the conflict through contending coalitions of policy actors operating across the Atlantic. Governing the Transatlantic Conflict over Agricultural Biotechnology focuses on interactions between the EU and the US, rather than on EU-US comparisons. Drawing on original research and interviews with key policy actors, the book shows how EU-US efforts to harmonise regulations for agricultural biotechnology created the context in which activists could generate a backlash against the technology. In this new context regulations were shaped along different lines. Joseph Murphy and Les Levidow provide new insights by elaborating critical perspectives on global governance, issue-framing, standard-setting and regulatory science.

This accessible book will appeal to undergraduate and post-graduate students, academics and policy-makers working on a wide range of issues covered by political science, policy studies, international relations, economics, geography, business management, environmental and development studies, science and technology studies.

Delays in approving genetically modified crops and foods in the European Union have led to a high profile trade conflict with the United States. This book analyses the EU-US conflict and uses it as a case study to explore the governance of new technologies.

The transatlantic conflict over GM crops and food has been widely attributed to regulatory differences that divide the EU and the US. Going beyond common stereotypes of these differences and their origins, this book analyses the conflict through contending coalitions of policy actors operating across the Atlantic. Governing the Transatlantic Conflict over Agricultural Biotechnology focuses on interactions between the EU and the US, rather than on EU-US comparisons. Drawing on original research and interviews with key policy actors, the book shows how EU-US efforts to harmonise regulations for agricultural biotechnology created the context in which activists could generate a backlash against the technology. In this new context regulations were shaped along different lines. Joseph Murphy and Les Levidow provide new insights by elaborating critical perspectives on global governance, issue-framing, standard-setting and regulatory science.

This accessible book will appeal to undergraduate and post-graduate students, academics and policy-makers working on a wide range of issues covered by political science, policy studies, international relations, economics, geography, business management, environmental and development studies, science and technology studies.

Europe was told that it had no choice but to accept agbiotech, yet this imperative was turned into a test of democratic accountability for societal choices. Since the late 1990s, European public controversy has kept the agri-biotech industry and its promoters on the defensive. As some opponents and regulators alike have declared, ‘GM food/crops are on trial’. Suspicion of their guilt has been evoked by moral symbols, as disputes over whether genetically-modified products are modest benign improvements on traditional plant breeding, or dangerous Frankenfoods; and in disputes over whether they are global saviours, or control agents of multinational companies. This book examines European institutions being ‘put on trial’ for how their regulatory procedures evaluate and regulate GM products, in ways which opened up alternative futures. Levidow and Carr highlight how public controversy created a legitimacy crisis, leading to national policy changes and demands, in turn stimulating changes in EU agbiotech regulations as a strategy to regain legitimacy.

Europe was told that it had no choice but to accept agbiotech, yet this imperative was turned into a test of democratic accountability for societal choices. Since the late 1990s, European public controversy has kept the agri-biotech industry and its promoters on the defensive. As some opponents and regulators alike have declared, ‘GM food/crops are on trial’. Suspicion of their guilt has been evoked by moral symbols, as disputes over whether genetically-modified products are modest benign improvements on traditional plant breeding, or dangerous Frankenfoods; and in disputes over whether they are global saviours, or control agents of multinational companies. This book examines European institutions being ‘put on trial’ for how their regulatory procedures evaluate and regulate GM products, in ways which opened up alternative futures. Levidow and Carr highlight how public controversy created a legitimacy crisis, leading to national policy changes and demands, in turn stimulating changes in EU agbiotech regulations as a strategy to regain legitimacy.